WATCH: NovAccess Global Leaders Discuss the FDA’s Recent Orphan Drug Designation of Their Technology
Автор: NovAccess Global, Inc.
Загружено: 2022-11-01
Просмотров: 44
Описание: In this episode of MoneyTV with Donald Baillargeon, interviewees include NovAccess Global CEO, Dwain Irvin, Ph.D., M.P.H., Board Member Jason Anderson, and StemVax Therapeutics President, Chris Wheeler, Ph.D. The discussion includes the public biotech company’s recent news of FDA’s Orphan Drug designation of NovAccess Global’s patented TLR-AD1 therapy candidate.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: